X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9524) 9524
Newsletter (290) 290
Book Chapter (57) 57
Magazine Article (30) 30
Newspaper Article (26) 26
Book / eBook (6) 6
Publication (5) 5
Conference Proceeding (2) 2
Web Resource (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7507) 7507
male (4124) 4124
antifungal agents - therapeutic use (3574) 3574
aspergillosis (3479) 3479
female (3439) 3439
aspergillosis - drug therapy (3386) 3386
middle aged (2637) 2637
adult (2573) 2573
infectious diseases (1840) 1840
microbiology (1754) 1754
aged (1686) 1686
invasive aspergillosis (1594) 1594
voriconazole (1562) 1562
animals (1339) 1339
aspergillosis - diagnosis (1276) 1276
amphotericin b - therapeutic use (1267) 1267
pharmacology & pharmacy (1254) 1254
aspergillosis - microbiology (1218) 1218
diagnosis (1204) 1204
pulmonary aspergillosis (1199) 1199
treatment outcome (1191) 1191
antifungal agents - administration & dosage (1160) 1160
mycoses (1133) 1133
adolescent (1092) 1092
antifungal agents (1062) 1062
amphotericin-b (1043) 1043
aspergillus (1038) 1038
immunology (986) 986
immunocompromised host (972) 972
fungal-infections (955) 955
itraconazole (955) 955
mycoses - drug therapy (953) 953
infections (934) 934
health aspects (902) 902
child (894) 894
risk factors (889) 889
antifungal agents - pharmacology (868) 868
mycology (839) 839
aspergillus fumigatus (834) 834
therapy (827) 827
transplantation (827) 827
lung diseases, fungal - drug therapy (823) 823
retrospective studies (816) 816
triazoles - therapeutic use (814) 814
care and treatment (767) 767
aspergillosis - complications (757) 757
aspergillosis - etiology (678) 678
invasive pulmonary aspergillosis (675) 675
fungal infections (663) 663
hematology (663) 663
research (653) 653
amphotericin b (645) 645
epidemiology (643) 643
drug therapy, combination (637) 637
candidiasis - drug therapy (628) 628
mice (609) 609
amphotericin b - administration & dosage (608) 608
aspergillus fumigatus - isolation & purification (597) 597
antifungal agents - adverse effects (589) 589
mortality (586) 586
infection (582) 582
liposomal amphotericin-b (570) 570
respiratory system (559) 559
young adult (555) 555
drug therapy (547) 547
aspergillus fumigatus - drug effects (545) 545
fungi (544) 544
microbial sensitivity tests (544) 544
itraconazole - therapeutic use (537) 537
aspergillus - isolation & purification (536) 536
fluconazole (529) 529
tomography, x-ray computed (529) 529
pyrimidines - therapeutic use (525) 525
caspofungin (512) 512
oncology (497) 497
child, preschool (493) 493
surgery (492) 492
aspergillosis, allergic bronchopulmonary - drug therapy (486) 486
aspergillosis - pathology (477) 477
medicine, general & internal (468) 468
cancer (467) 467
allergic bronchopulmonary aspergillosis (460) 460
efficacy (459) 459
neutropenia (455) 455
disease (447) 447
pharmacokinetics (447) 447
lipopeptides (438) 438
fumigatus (437) 437
pediatrics (433) 433
candidiasis (432) 432
antifungal agents - pharmacokinetics (424) 424
neutropenic patients (420) 420
patients (419) 419
aged, 80 and over (417) 417
fatal outcome (414) 414
echinocandins (403) 403
diagnosis, differential (402) 402
invasive fungal-infections (398) 398
veterinary sciences (394) 394
medicine & public health (392) 392
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9027) 9027
French (246) 246
Japanese (214) 214
German (193) 193
Spanish (158) 158
Russian (57) 57
Chinese (44) 44
Polish (37) 37
Italian (29) 29
Portuguese (13) 13
Dutch (12) 12
Turkish (11) 11
Czech (7) 7
Danish (7) 7
Hungarian (4) 4
Finnish (3) 3
Romanian (3) 3
Hebrew (2) 2
Norwegian (2) 2
Swedish (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Croatian (1) 1
Estonian (1) 1
Korean (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Medicine, The, ISSN 0002-9343, 2012, Volume 125, Issue 1, pp. S25 - S38
Abstract Effective management of invasive fungal infections (IFIs) depends on early individualized therapy that optimizes efficacy and safety... 
Internal Medicine | Therapeutic drug monitoring | Echinocandins | Mucormycosis | Amphotericin B | Triazoles | Hepatotoxicity | DISSEMINATED ZYGOMYCOSIS | IN-VITRO SUSCEPTIBILITIES | BREAKTHROUGH FUNGAL-INFECTIONS | PREEMPTIVE ANTIFUNGAL THERAPY | LIPOSOMAL AMPHOTERICIN-B | CLINICAL-PRACTICE GUIDELINES | CELL TRANSPLANT RECIPIENTS | MEDICINE, GENERAL & INTERNAL | SALVAGE THERAPY | INFECTIOUS-DISEASES-SOCIETY | DRUG-DRUG INTERACTIONS | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Humans | Middle Aged | Mycoses - microbiology | Male | Alanine Transaminase - blood | Antineoplastic Agents - administration & dosage | Echinocandins - administration & dosage | Liver - drug effects | Antineoplastic Agents - adverse effects | Antifungal Agents - pharmacokinetics | Mycoses - metabolism | Adult | Female | Mucormycosis - surgery | Mucormycosis - drug therapy | Alkaline Phosphatase - blood | Myelodysplastic Syndromes - drug therapy | Aspergillosis - drug therapy | Flucytosine - administration & dosage | Liver - metabolism | Risk Factors | Leukemia - drug therapy | Mycoses - surgery | Pneumonia - microbiology | Biomarkers - blood | Bilirubin - blood | Flucytosine - adverse effects | Echinocandins - adverse effects | Pneumonia - drug therapy | Aspartate Aminotransferases - blood | Liver Function Tests - standards | Opportunistic Infections - drug therapy | Mycoses - drug therapy | Immunocompromised Host | Drug Monitoring | Antifungal Agents - administration & dosage | Care and treatment | Mycoses | Diagnosis | Research | Health aspects | Risk factors | Drugs | flucytosine | Pharmacodynamics | Risk groups | Mortality | Antifungal agents | Molds | triazoles | Epidemiology | Radicals | Infection | Lipophilic | hepatotoxicity | Voriconazole | Pharmacokinetics | Posaconazole | Itraconazole
Journal Article
Annals of hematology, ISSN 1432-0584, 2013, Volume 93, Issue 1, pp. 13 - 32
The Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) here presents its updated recommendations for the... 
Hematologic malignancies | Invasive candidiasis | Medicine & Public Health | Hematology | Antifungal agents | Aspergillosis | Mycoses | Oncology | PERSISTENT FEBRILE NEUTROPENIA | NERVOUS-SYSTEM ASPERGILLOSIS | CHRONIC DISSEMINATED CANDIDIASIS | ACUTE MYELOID-LEUKEMIA | CATHETER-RELATED INFECTIONS | LIPOSOMAL AMPHOTERICIN-B | TRICHOSPORON-ASAHII INFECTION | CLINICAL-PRACTICE GUIDELINES | HIGH-DOSE FLUCONAZOLE | SCEDOSPORIUM-PROLIFICANS INFECTION | HEMATOLOGY | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Humans | Salvage Therapy | Catheter-Related Infections - prevention & control | Antifungal Agents - therapeutic use | Echinocandins - administration & dosage | Neoplasms - complications | Invasive Pulmonary Aspergillosis - etiology | Fungemia - drug therapy | Immunotherapy | Candidiasis, Invasive - drug therapy | Amphotericin B - administration & dosage | Mycoses - therapy | Drug Therapy, Combination | Candidiasis, Invasive - etiology | Triazoles - therapeutic use | Invasive Pulmonary Aspergillosis - drug therapy | Mycoses - surgery | Clinical Trials as Topic | Combined Modality Therapy | Chemotherapy-Induced Febrile Neutropenia - complications | Fungemia - prevention & control | Catheter-Related Infections - drug therapy | Amphotericin B - adverse effects | Echinocandins - adverse effects | Invasive Pulmonary Aspergillosis - surgery | Mycoses - drug therapy | Echinocandins - therapeutic use | Immunocompromised Host | Amphotericin B - therapeutic use | Drug Monitoring | Antifungal Agents - administration & dosage | Mycoses - etiology | Cancer patients | Care and treatment | Chemotherapy | Mortality | Clinical trials | Health aspects | Cancer | Original
Journal Article
Drug resistance updates, ISSN 1368-7646, 2015, Volume 21-22, pp. 30 - 40
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 4/2009, Volume 48, Issue 8, pp. 1042 - 1051
Journal Article
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2011, Volume 52, Issue 9, pp. 1123 - 1129
Background. Oral triazole therapy is well established for the treatment of invasive (IPA), allergic (ABPA... 
Polymerase chain reaction | Antifungals | Aspergillus | Azoles | Triazoles | Aspergillosis | Sputum | ARTICLES AND COMMENTARIES | Allergic bronchopulmonary aspergillosis | Aspergillus fumigatus | Genetic mutation | DIAGNOSIS | INFECTIOUS DISEASES | SEVERE ASTHMA | MICROBIOLOGY | ITRACONAZOLE | IMMUNOLOGY | TRIAL | INVASIVE ASPERGILLOSIS | PULMONARY ASPERGILLOSIS | SENSITIZATION | AZOLE RESISTANCE | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | PCR | Aspergillus fumigatus - drug effects | Sputum - microbiology | Lung - microbiology | Aspergillosis, Allergic Bronchopulmonary - microbiology | Humans | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Antifungal Agents - therapeutic use | Bronchoalveolar Lavage Fluid - microbiology | Aspergillus fumigatus - isolation & purification | Culture Media | Polymerase Chain Reaction | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Invasive Pulmonary Aspergillosis - epidemiology | Triazoles - therapeutic use | Antifungal Agents - pharmacology | Invasive Pulmonary Aspergillosis - drug therapy | Pulmonary Aspergillosis - drug therapy | DNA, Fungal - analysis | Drug Resistance, Fungal - genetics | Aspergillus fumigatus - genetics | Pulmonary Aspergillosis - microbiology | Triazoles - pharmacology | Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - microbiology | Mutation | Chronic Disease | Drug resistance in microorganisms | Usage | Physiological aspects | Causes of | Lung diseases, Fungal | Research | Drug therapy | Health aspects | and Commentaries
Journal Article